Literature DB >> 20225930

The sex ratio in amyotrophic lateral sclerosis: A population based study.

Zita R Manjaly1, Kirsten M Scott, Kumar Abhinav, Lokesh Wijesekera, Jeban Ganesalingam, Laura H Goldstein, Anna Janssen, Andrew Dougherty, Emma Willey, Biba R Stanton, Martin R Turner, Mary-Ann Ampong, Mohammed Sakel, Richard W Orrell, Robin Howard, Chris E Shaw, P Nigel Leigh, Ammar Al-Chalabi.   

Abstract

Replicable risk factors for ALS include increasing age, family history and being male. The male: female ratio has been reported as being between 1 and 3. We tested the hypothesis that the sex ratio changes with age in a population register covering the south-east of England. The sex ratio before and after the age of 51 years was compared using a Z-test for proportions. Kendall's tau was used to assess the relationship between age group and sex ratio using incidence and prevalence data. Publicly available data from Italian and Irish population registers were compared with results. There was a significant difference in the proportion of females with ALS between those in the younger group (30.11%) and those in the older group (43.66%) (p = 0.013). The adjusted male: female ratio dropped from 2.5 in the younger group to 1.4 in the older group using prevalence data (Kendall's tau = -0.73, p = 0.039). Similar ratios were found in the Italian but not the Irish registry. We concluded that sex ratios in ALS may change with age. Over-representation of younger patients in clinic registers may explain the variation in sex ratios between studies. Menopause may also play a role.

Entities:  

Mesh:

Year:  2010        PMID: 20225930      PMCID: PMC6485484          DOI: 10.3109/17482961003610853

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  12 in total

Review 1.  The epidemiology of ALS and the role of population-based registries.

Authors:  Ettore Beghi; Giancarlo Logroscino; Adriano Chiò; Orla Hardiman; Douglas Mitchell; Robert Swingler; Bryan J Traynor
Journal:  Biochim Biophys Acta       Date:  2006-09-29

2.  Incidence of ALS in Lombardy, Italy.

Authors:  E Beghi; A Millul; A Micheli; E Vitelli; G Logroscino
Journal:  Neurology       Date:  2007-01-09       Impact factor: 9.910

3.  Incidence of ALS in Italy: evidence for a uniform frequency in Western countries.

Authors: 
Journal:  Neurology       Date:  2001-01-23       Impact factor: 9.910

Review 4.  Amyotrophic lateral sclerosis: toxins and environment.

Authors:  J D Mitchell
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-09

Review 5.  An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis.

Authors:  Carmel Armon
Journal:  Neuroepidemiology       Date:  2003 Jul-Aug       Impact factor: 3.282

6.  Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study.

Authors:  B J Traynor; M B Codd; B Corr; C Forde; E Frost; O Hardiman
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

Review 7.  Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues.

Authors:  G Logroscino; B J Traynor; O Hardiman; A Chio'; P Couratier; J D Mitchell; R J Swingler; E Beghi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-01       Impact factor: 10.154

8.  The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over.

Authors:  Raeburn B Forbes; Shuna Colville; Robert J Swingler
Journal:  Age Ageing       Date:  2004-03       Impact factor: 10.668

9.  Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004.

Authors:  O O'Toole; B J Traynor; P Brennan; C Sheehan; E Frost; B Corr; O Hardiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07-18       Impact factor: 10.154

10.  Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry).

Authors:  K Abhinav; B Stanton; C Johnston; J Hardstaff; R W Orrell; R Howard; J Clarke; M Sakel; M-A Ampong; C E Shaw; P N Leigh; A Al-Chalabi
Journal:  Neuroepidemiology       Date:  2007-09-24       Impact factor: 3.282

View more
  57 in total

Review 1.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

Review 2.  Do Microglial Sex Differences Contribute to Sex Differences in Neurodegenerative Diseases?

Authors:  Lay Kodama; Li Gan
Journal:  Trends Mol Med       Date:  2019-06-03       Impact factor: 11.951

Review 3.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

Review 4.  Gene discovery in amyotrophic lateral sclerosis: implications for clinical management.

Authors:  Ammar Al-Chalabi; Leonard H van den Berg; Jan Veldink
Journal:  Nat Rev Neurol       Date:  2016-12-16       Impact factor: 42.937

5.  Endogenous female reproductive hormones and the risk of amyotrophic lateral sclerosis.

Authors:  Sonja de Jong; Mark Huisman; Nadia Sutedja; Anneke van der Kooi; Marianne de Visser; Jurgen Schelhaas; Yvonne van der Schouw; Jan Veldink; Leonard van den Berg
Journal:  J Neurol       Date:  2012-09-13       Impact factor: 4.849

6.  Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice.

Authors:  Lien-Szu Wu; Wei-Cheng Cheng; C-K James Shen
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

7.  Flavin-containing monooxygenase mRNA levels are up-regulated in als brain areas in SOD1-mutant mice.

Authors:  Stella Gagliardi; Paolo Ogliari; Annalisa Davin; Manuel Corato; Emanuela Cova; Kenneth Abel; John R Cashman; Mauro Ceroni; Cristina Cereda
Journal:  Neurotox Res       Date:  2010-11-17       Impact factor: 3.911

Review 8.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

9.  Tollgate-based progression pathways of ALS patients.

Authors:  Özden O Dalgıç; F Safa Erenay; Kalyan S Pasupathy; Osman Y Özaltın; Brian A Crum; Mustafa Y Sir
Journal:  J Neurol       Date:  2019-01-25       Impact factor: 4.849

10.  Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1.

Authors:  Kreshnik B Ahmeti; Senda Ajroud-Driss; Ammar Al-Chalabi; Peter M Andersen; Jennifer Armstrong; Anne Birve; Hylke M Blauw; Robert H Brown; Lucie Bruijn; Wenjie Chen; Adriano Chio; Mary C Comeau; Simon Cronin; Frank P Diekstra; Athina Soraya Gkazi; Jonathan D Glass; Josh D Grab; Ewout J Groen; Jonathan L Haines; Orla Hardiman; Scott Heller; Jie Huang; Wu-Yen Hung; James M Jaworski; Ashley Jones; Humaira Khan; John E Landers; Carl D Langefeld; P Nigel Leigh; Miranda C Marion; Russell L McLaughlin; Vincent Meininger; Judith Melki; Jack W Miller; Gabriele Mora; Margaret A Pericak-Vance; Evadnie Rampersaud; Wim Robberecht; Laurie P Russell; Francois Salachas; Christiaan G Saris; Aleksey Shatunov; Christopher E Shaw; Nailah Siddique; Teepu Siddique; Bradley N Smith; Robert Sufit; Simon Topp; Bryan J Traynor; Caroline Vance; Philip van Damme; Leonard H van den Berg; Michael A van Es; Paul W van Vught; Jan H Veldink; Yi Yang; J G Zheng
Journal:  Neurobiol Aging       Date:  2012-09-05       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.